Weill Cornell Bone Marrow Transplant Program

Brincidofovir for CMV Infection

Leave a comment

CMV virus can cause considerable problems after allogeneic transplantation. Dr. Tsiporah Shore was an important contributor to a recent study of brincidofovir for prevention of CMV virus.  The results of this study were presented at ASBMT in Honolulu, Hawaii and received an award for best abstract.

Brincidofovir for Prevention of Cytomegalovirus (CMV) after Allogeneic Hematopoietic Cell Transplantation (HCT) in CMV-Seropositive Patients: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Phase 3 Trial

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

w

Connecting to %s